ATE336231T1 - Verfahren zur herstellung kristalliner arzneimittelteilchen durch ausfällung - Google Patents

Verfahren zur herstellung kristalliner arzneimittelteilchen durch ausfällung

Info

Publication number
ATE336231T1
ATE336231T1 AT02801623T AT02801623T ATE336231T1 AT E336231 T1 ATE336231 T1 AT E336231T1 AT 02801623 T AT02801623 T AT 02801623T AT 02801623 T AT02801623 T AT 02801623T AT E336231 T1 ATE336231 T1 AT E336231T1
Authority
AT
Austria
Prior art keywords
solvent
mixing zone
precipitation
producing crystalline
recirculating
Prior art date
Application number
AT02801623T
Other languages
English (en)
Inventor
James E Hitt
Christopher J Tucker
Jonathan C Evans
Cathy A Curtis
Sonke Svenson
Original Assignee
Dow Global Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Global Technologies Inc filed Critical Dow Global Technologies Inc
Application granted granted Critical
Publication of ATE336231T1 publication Critical patent/ATE336231T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02801623T 2001-08-29 2002-08-27 Verfahren zur herstellung kristalliner arzneimittelteilchen durch ausfällung ATE336231T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31556001P 2001-08-29 2001-08-29

Publications (1)

Publication Number Publication Date
ATE336231T1 true ATE336231T1 (de) 2006-09-15

Family

ID=23224987

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02801623T ATE336231T1 (de) 2001-08-29 2002-08-27 Verfahren zur herstellung kristalliner arzneimittelteilchen durch ausfällung

Country Status (6)

Country Link
US (1) US20030049323A1 (de)
EP (1) EP1423096B1 (de)
AT (1) ATE336231T1 (de)
CA (1) CA2458889C (de)
DE (1) DE60214012T2 (de)
WO (1) WO2003032951A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004534811A (ja) * 2001-06-22 2004-11-18 ファイザー・プロダクツ・インク ポリマーと薬剤の集合体を含む医薬組成物
DE10214031A1 (de) * 2002-03-27 2004-02-19 Pharmatech Gmbh Verfahren zur Herstellung und Anwendung von Mikro- und Nanoteilchen durch aufbauende Mikronisation
ES2312996T3 (es) * 2003-04-29 2009-03-01 N.V. Organon Proceso de solidificacion con antidisolvente.
DK1631261T3 (da) 2003-05-22 2009-11-09 Applied Nanosystems Bv Fremstilling af små partikler
EP1688169A4 (de) * 2003-11-28 2008-10-01 Mitsubishi Chem Corp Verfahren zur herstellung von feinen teilchen einer organischen verbindung
US9682043B2 (en) * 2003-12-09 2017-06-20 Medcrystalforms, Llc Method of preparation of mixed phase co-crystals with active agents
EP1730516A1 (de) * 2004-03-30 2006-12-13 Pfizer Products Incorporated Verfahren und vorrichtung zur bewertung pharmazeutischer zusammensetzungen
EP1789018A1 (de) * 2004-08-27 2007-05-30 The Dow Chemical Company Verbesserte abgabe von medikamentenzusammensetzungen zur behandlung lebensbedrohender infektionen
EP1797934A4 (de) * 2004-09-07 2009-09-02 Mitsubishi Chem Corp Verfahren zur herstellung einer feinteiligen substanz und feinteilige substanz
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
DK1957086T3 (en) * 2005-11-18 2018-06-06 Cornell Res Foundation Inc NICOTINOYL RIBOSIDE COMPOSITIONS AND METHODS OF USE
JP5592647B2 (ja) * 2006-04-28 2014-09-17 メルク・シャープ・アンド・ドーム・コーポレーション 制御された析出による６，６−ジメチル−３−アザ−ビシクロ［３．１．０］ヘキサン−アミド化合物の析出および単離のための方法、ならびにこれを含む医薬処方物
US8420122B2 (en) * 2006-04-28 2013-04-16 Merck Sharp & Dohme Corp. Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same
US20100062073A1 (en) * 2006-11-29 2010-03-11 Ronald Arthur Beyerinck Pharmaceutical compositions comprising nanoparticles comprising enteric polymers casein
GB0705159D0 (en) * 2007-03-19 2007-04-25 Prosonix Ltd Process for making crystals
US20100119612A1 (en) * 2007-04-17 2010-05-13 Bend Research, Inc Nanoparticles comprising non-crystalline drug
WO2008135828A2 (en) * 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
US8703204B2 (en) * 2007-05-03 2014-04-22 Bend Research, Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
US20100080852A1 (en) * 2007-05-03 2010-04-01 Ronald Arthur Beyerinck Phamaceutical composition comprising nanoparticles and casein
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
EP2162120B1 (de) * 2007-06-04 2016-05-04 Bend Research, Inc Nanopartikel mit nicht ionisierbarem zellulosepolymer und amphipilem nicht ionisierbarem blockcopolymer
GB0711680D0 (en) * 2007-06-18 2007-07-25 Prosonix Ltd Process
DK2170283T3 (en) 2007-06-22 2019-04-15 Univ Texas CREATION OF STABLE SUBMICRON Peptide OR PROTEIN PARTICLES BY THIN FILM FREEZING
EP2178518A2 (de) * 2007-07-13 2010-04-28 Bend Research, Inc Nanopartikel mit ionisierbaren und schwach wasserlöslichen zellulose-polymeren
US9724362B2 (en) * 2007-12-06 2017-08-08 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
US9233078B2 (en) * 2007-12-06 2016-01-12 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
WO2010003811A1 (en) * 2008-07-11 2010-01-14 Basf Se Amphiphilic proteins as morphology modifiers
DK2544663T3 (en) 2010-03-12 2018-04-16 Berg Llc INTRAVENOUS FORMULATIONS OF COENZYM Q10 (CoQ10) AND PROCEDURES FOR USING IT
AU2011305567A1 (en) 2010-09-22 2013-05-02 Map Pharmaceuticals, Inc. Corticosteroid particles and method of production
US20120311822A1 (en) * 2011-06-10 2012-12-13 Culkin Joseph B Solute crystallizing apparatus
JP5932993B2 (ja) 2011-06-17 2016-06-08 バーグ エルエルシー 吸入可能な医薬組成物
EP2601973A1 (de) 2011-12-09 2013-06-12 Laboratoires SMB SA Trockenpulverformulierung eines Azolderivats zum Inhalieren
DE102012221219B4 (de) * 2012-11-20 2014-05-28 Jesalis Pharma Gmbh Verfahren zur Vergrößerung der Partikelgröße kristalliner Wirkstoff-Mikropartikel
PT108368B (pt) * 2015-03-31 2018-11-05 Hovione Farm S A Produção contínua de partículas
JP2020514408A (ja) * 2017-01-23 2020-05-21 サビオール ライフテック コーポレーションＳａｖｉｏｒ Ｌｉｆｅｔｅｃ Ｃｏｒｐｏｒａｔｉｏｎ 有効成分微粒子の製造
CN109011674B (zh) * 2018-09-11 2020-08-11 安徽东至广信农化有限公司 一种用于硝基氯苯制备的蒸酸器
CN114502145A (zh) 2019-10-10 2022-05-13 拜耳股份有限公司 制备纳米微粒活性成分的方法
WO2026013055A1 (en) * 2024-07-09 2026-01-15 Hovione Farmaciência S.A., Methods and systems for preparing feed solutions for spray drying

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US624617A (en) * 1899-05-09 Insecticide
SU1126202A3 (ru) * 1976-05-28 1984-11-23 Институт Фор Атомэнерги (Фирма) Способ непрерывной многостадийной кристаллизации из раствора
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
JP3282731B2 (ja) * 1990-06-15 2002-05-20 メルク エンド カムパニー インコーポレーテッド 結晶の構造および大きさを改良する結晶化方法
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5716642A (en) * 1995-01-10 1998-02-10 Nano Systems L.L.C. Microprecipitation of nanoparticulate pharmaceutical agents using surface active material derived from similar pharmaceutical agents
SE9501384D0 (sv) * 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
DE59701724D1 (de) * 1996-07-05 2000-06-21 Haarmann & Reimer Gmbh Kristallisationsvorrichtung und -verfahren
DE19738085C1 (de) * 1997-09-01 1998-12-03 Basf Ag Verfahren zur Herstellung von Feststoffen durch Fällung
US5908589A (en) * 1997-12-08 1999-06-01 Twenty-First Century Research Corporation Methods for separating catalyst from oxidation mixtures containing dibasic acids
EP0930073B1 (de) * 1998-01-14 2004-08-04 National Research Development Corporation of India Verfahren zur Herstellung eines spermiziden Mittels
US6607651B2 (en) * 1998-09-10 2003-08-19 Cws Parts Company Process and system for treating the discharge stream from an ion exchanger
GB9828721D0 (en) * 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
GB9905512D0 (en) * 1999-03-10 1999-05-05 Smithkline Beecham Plc Process
TW526172B (en) * 1999-06-30 2003-04-01 Sumitomo Chemical Co A process for producing pentacyl-type crystalline zeolites and a process for producing ε-caprolactam using the same
GB9919693D0 (en) * 1999-08-19 1999-10-20 Rhone Poulenc Rorer Ltd Process
GB9925934D0 (en) * 1999-11-03 1999-12-29 Glaxo Group Ltd Novel apparatus and process
GB0016002D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
GB0015981D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
US6756062B2 (en) * 2000-11-03 2004-06-29 Board Of Regents University Of Texas System Preparation of drug particles using evaporation precipitation into aqueous solutions

Also Published As

Publication number Publication date
EP1423096B1 (de) 2006-08-16
US20030049323A1 (en) 2003-03-13
WO2003032951A1 (en) 2003-04-24
DE60214012T2 (de) 2006-12-21
CA2458889A1 (en) 2003-04-24
CA2458889C (en) 2011-06-21
EP1423096A1 (de) 2004-06-02
DE60214012D1 (de) 2006-09-28

Similar Documents

Publication Publication Date Title
ATE336231T1 (de) Verfahren zur herstellung kristalliner arzneimittelteilchen durch ausfällung
DK1158962T3 (da) Fremgangsmåde til fremstilling af faste cyclodextrinholdige doseringsformer
SE9501384D0 (sv) Process for the preparation of respirable particles
PT1180062E (pt) Metodo para a producao de micro e nanoparticulas morfologicamente uniformes utilizando micromisturadores
DE60029457D1 (de) Verfahren zur herstellung von feinkörnigen medizinischen substanzen
DE69426934D1 (de) Verfahren zur konditionierung von substanzen
ATE449596T1 (de) Verfahren zur herstellung von mikropartikeln
YU66003A (sh) Postupak za izdvajanje hemiceluloza iz biomase koja sadrži hemiceluloze kao i biomasa i hemiceluloze koje se mogu dobiti primenom ovog postupka
ATE297196T1 (de) Verfahren zur herstellung von nanometer partikeln durch fliessbett- sprühtrocknung
ATE302786T1 (de) Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv
DE50205571D1 (de) Verfahren zur Herstellung von direkt tablettierbaren Beta-Mannit
ATE327737T1 (de) Verfahren zur herstellung von arzneistoffgranulatkörnern, die arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische zubereitungen
EP1862431A8 (de) Herstellungsverfahren für inp-mikroteilchen und mit diesem verfahren hergestellte inp-mikroteilchen-dispersionslösung
ATE230987T1 (de) Pranlukast enthaltende granula, verfahren zur herstellung der granula und verfahren zur verminderung des zusammenbackens von pranlukast
DK1583538T3 (da) Anvendelse af 3-methozy-pregnenolon til fremstilling af et lægemiddel til behandling af neurodegenerative sygdomme
BR0318104A (pt) Processos para a fabricação de materiais de filtros para água e filtros para água
DE602004000665D1 (de) Biologisches Verfahren zur Herstellung eines Hämeisenpräparats und daraus hergestellte Nahrungsmittelprodukte
PL347070A1 (en) Crystal of diuridine tetraphosphate or salt thereof and method for preparing the same, and method for producing said compound
GB0120123D0 (en) Preparation of microparticles
ATE298567T1 (de) Pharmazeutische zusammensetzung enthaltend ibuprofen und ein verfahren zur deren herstellung
DE59913913D1 (de) Verfahren zur herstellung von kleinen sphärischen partikeln, die mindestens ein wasserunlösliches lineares polysaccharid enthalten
ATE395086T1 (de) Verfahren zur herstellung von einschlussverbindungen zwischen einem nichtsteroidalen antirheumatikum und betacyclodextrin durch mikrowellenbehandlung
DE50301507D1 (de) 17a-FLUORALKYL-11BETA-BENZALDOXIM-STEROIDE, VERFAHREN ZU DEREN HERSTELLUNG, DIESE STEROIDE ENTHALTENDE PHARMAZEUTISCHE PRÄPARATE SOWIE DEREN VERWENDUNG ZUR HERSTELLUNG VON ARZNEIMITTELN
SG153663A1 (en) Process for the production of biodegradable, functionalised polymer particles and use thereof as pharmaceutical supports
ATE277963T1 (de) Verfahren und vorrichtung zur herstellung von cellulosepartikeln

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties